1Sosenko J M,Palmer J P,Greenbaum C J,et al.Diabetes Prevention Trial-Type 1 Study Group.Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes:the Diabetes Prevention Trial-Type 1.Diabetes Care,2007,30:38-42.
2Breda E,Cavaghan M K,Toffolo G,et al.Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity.Diabetes,2001,50:150-158.
3Sakaue S,Ishimaru S,Ikeda D,et al.Estimation of beta-cell function from the data of the oral glucose tolerance test.Am J Physiol Endocrinol Metab,2007,292:E1575-E1580.
4Wallander M,Malmberg K,Norhammar A,et al.Oral glucose tolerance test:a reliable tool for early detection of glucose abnormalities in patients with acute myocardial infarction in clinical practice:a report on repeated oral glucose tolerance tests from the GAMI study.Diabetes Care,2008,31:36-38.
8Matsuda M,DeFronzo R A.Insulin sensitivity indices obtained from oral glucose tolerance testing:comparison with the euglycemic insulin clamp.Diabetes Care,1999,22:1462-1470.
9Dedik L,Durisova M,Penesovd A,et al.Estimation of influence of gastric emptying on shape of glucose concentration-time profile measured in oral glucose tolerance test.Diabetes Res Clin Pract,2007,77:377-384.
10Anderberg E,Kallen K,Berntorp K,et al.A simplified oral glucose tolerance test in pregnancy:compliance and results.Acta Obstet Gynecol Scand,2007,86:1432-1436.
6[1]DeFronzo PA.Lilly lecture, 1987.The triumvirate:β-cell, mus cle, liver. A collusion responsible for NIDDM. Diabetes, 1988,37: 667-687.
7[2]Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis mod el assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia,1985, 28:412-419.
8[3]DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care, 1992,15:318 368.
9[4]Saad MF, Knowler WC, Pettitt DJ, et al. Sequential changes in serum insulin concentration during development of non-insulin-de pendent diabetes. Lancet, 1989,1 (8651):1356-1359.
10[3]American Diabetes Association. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care, 2002(suppl1):S50-S60.
